Patel Chem Specialities FY26 Revenue Rises 30%, Eyes Capacity Expansion

CHEMICALS
Whalesbook Corporate News Logo
AuthorKavya Nair|Published at:
Patel Chem Specialities FY26 Revenue Rises 30%, Eyes Capacity Expansion

Patel Chem Specialities Ltd posted a 30.6% jump in FY26 revenue to Rs 137.26 crore, with PAT growing 18.8%. The company is aggressively scaling operations, headlined by the Talod plant expansion and a new facility at Indrad, Gujarat. While no dividend was declared to conserve cash for these capital expenditures, the firm is leveraging IPO proceeds to drive future volume growth.

Patel Chem Specialities Reports Strong FY26 Growth

Revenue: Rs 137.26 crore (up 30.61% YoY). Profit After Tax: Rs 12.55 crore (up 18.81% YoY).

Reader Takeaway: Strong top-line growth and major capacity expansion, but no dividends due to focus on capital investment.

What just happened

Patel Chem Specialities Limited has announced its financial performance for FY2025-26, highlighting a period of significant scaling. The company reported a revenue of Rs 137.26 crore, marking a 30.61% increase year-over-year. Profits followed a similar trajectory, rising by 18.81% to reach Rs 12.55 crore, driven by robust market demand for its chemical products.

Why this matters

The company is in a heavy growth phase. The completion of the Talod plant expansion, which lifts capacity from 720 MT to 4,500 MTPA, serves as a primary growth lever. Simultaneously, construction is underway for a new facility in Indrad, Gujarat, aimed at diversifying production into Croscarmellose Sodium, Sodium Starch Glycolate, and Calcium CMC.

Corporate Developments and IPO

The company successfully listed on the BSE SME platform on 1 August 2025, raising Rs 58.80 crore through an IPO. As of 31 March 2026, the company had utilized Rs 22.56 crore of the proceeds for capital expenditure, with the remaining Rs 36.24 crore held in fixed deposits to fund ongoing project construction.

Risks to watch

Investors should track the commercialization timeline of the Talod facility and the construction progress of the Indrad plant. Any delays in operationalizing these assets could impact the company's ability to maintain its aggressive growth trajectory. Additionally, the company has opted not to pay a dividend to prioritize profit conservation for these projects.

What to track next

The 18th Annual General Meeting is scheduled for 25 September 2026 in Ahmedabad. Shareholders will vote on financial statements and proposed related-party transactions worth up to Rs 65 crore.

Disclaimer: This article is published for informational purposes only. This is not a buy sell recommendation.